Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells (Q57220366)

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Modulation of life and death by the TNF receptor superfamily

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Therapeutic modulation of death receptor- or drug-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Mitochondria and apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Roles of lipid rafts in membrane transport

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Mitochondrial control of cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

NF-kappaB signals induce the expression of c-FLIP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

The potential of TRAIL for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Two CD95 (APO-1/Fas) signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

TRAIL causes cleavage of bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206127

7 January 2021